Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies.
J Headache Pain
; 22(1): 141, 2021 Nov 24.
Article
in En
| MEDLINE
| ID: mdl-34819017
Full text:
1
Database:
MEDLINE
Main subject:
Migraine Disorders
/
Antibodies, Monoclonal
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Aged
/
Humans
Language:
En
Journal:
J Headache Pain
Journal subject:
MEDICINA INTERNA
/
NEUROLOGIA
/
PSICOFISIOLOGIA
Year:
2021
Type:
Article
Affiliation country:
United States